Renaissance Technologies’s Instil Bio TIL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$387K Sell
50,300
-8,800
-15% -$71K ﹤0.01% 2701
2026
Q1
$487K Sell
59,100
-8,700
-13% -$70.6K ﹤0.01% 2608
2025
Q4
$746K Buy
+67,800
New +$1M ﹤0.01% 2409
2025
Q3
Sell
-70,655
Closed -$1.47M 3918
2025
Q2
$1.47M Sell
70,655
-34,288
-33% -$717K ﹤0.01% 2300
2025
Q1
$1.82M Sell
104,943
-28,812
-22% -$598K ﹤0.01% 2067
2024
Q4
$2.55M Buy
133,755
+36,900
+38% +$1.13M ﹤0.01% 1890
2024
Q3
$6.52M Sell
96,855
-19,400
-17% -$457K 0.01% 1281
2024
Q2
$1.2M Sell
116,255
-10,000
-8% -$108K ﹤0.01% 2217
2024
Q1
$1.36M Buy
126,255
+12,641
+11% +$139K ﹤0.01% 2282
2023
Q4
$866K Buy
113,614
+61,343
+117% +$444K ﹤0.01% 2502
2023
Q3
$447K Sell
52,271
-11,130
-18% -$112K ﹤0.01% 2756
2023
Q2
$699K Buy
63,401
+22,535
+55% +$275K ﹤0.01% 2696
2023
Q1
$540K Sell
40,866
-23,355
-36% -$345K ﹤0.01% 2847
2022
Q4
$809K Buy
+64,221
New +$3.17M ﹤0.01% 2659
2022
Q3
Sell
-17,752
Closed -$1.64M 4407
2022
Q2
$1.64M Buy
+17,752
New +$2.51M ﹤0.01% 2341

Other funds holding TIL

Renaissance Technologies's TIL Position: Q2 2026 in Review

Renaissance Technologies reduced its Instil Bio (TIL) stake by 15% in Q2 2026, selling an estimated $71K and leaving 50,300 shares worth $387K. The position accounts for ﹤0.01% of the portfolio, ranked #2701.

Renaissance Technologies first reported a position in TIL in Q2 2022 and has held it in 15 quarters since. The position peaked at $6.52M in Q3 2024. 26 funds tracked by Wall St. Rank hold TIL as of Q2 2026.

  • Renaissance Technologies held 50,300 shares of Instil Bio worth $387K as of Q2 2026.
  • Renaissance Technologies sold 8,800 Instil Bio shares in Q2 2026, an estimated $71K.
  • Instil Bio made up ﹤0.01% of Renaissance Technologies's portfolio in Q2 2026, its #2701 holding.
  • Renaissance Technologies first reported a position in Instil Bio in Q2 2022 and has held it in 15 quarters since.
  • Renaissance Technologies's Instil Bio position peaked at $6.52M in Q3 2024.
  • 26 funds tracked by Wall St. Rank held Instil Bio as of Q2 2026.

Based on Renaissance Technologies's 13F filing for Q2 2026, filed 13 Aug 2026.